Acceder

Publicaciones - Investigación en Pediatría

Cargando...
Kuter DJ, Bonkovsky HL, Monroy S, Ross G, Guillen-Navarro E, Cappellini MD, Minder AE, Hother-Nielsen O, Ventura P, Jia G, Sweetser MT, Thapar M; ENVISION Investigators. Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. J Hepatol. 2023 Nov;79(5):1150-1158. doi: 10.1016/j.jhep.2023.06.013. Epub 2023 Jul 20. PubMed PMID: 37479139.
AÑO: 2023; IF: 25.7
Maghnie M, Semler O, Guillen-Navarro E, Selicorni A, Heath KE, Haeusler G, Hagenas L, Merker A, Leiva-Gea A, Gonzalez VL, Raimann A, Rehberg M, Santos-Simarro F, Ertl DA, Gregersen PA, Onesimo R, Landfeldt E, Jarrett J, Quinn J, Rowell R, Pimenta J, Cohen S, Butt T, Shediac R, Mukherjee S, Mohnike K. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. Orphanet J Rare Dis. 2023 Mar 15;18(1):56. doi: 10.1186/s13023-023-02652-2. PubMed PMID: 36922864; PubMed Central PMCID: PMC10015810.
AÑO: 2023; IF: 3.7
Urrutia-Pereira M, Mocelin LP, Ellwood P, Garcia-Marcos L, Simon L, Rinelli P, Chong-Neto HJ, Sole D. Prevalence of rhinitis and associated factors in adolescents and adults: a Global Asthma Network study. Rev Paul Pediatr. 2023 Mar 3;41:e2021400. doi: 10.1590/1984-0462/2023/41/2021400. eCollection 2023. PubMed PMID: 36888752; PubMed Central PMCID: PMC9984151.
AÑO: 2023; IF: 1.7
Barreda-Sanchez M, Guillen-Navarro E. From basic research to clinical practice: RNA interference. Med Clin (Barc). 2023 Sep;159 Suppl 1:S33-S37. doi: 10.1016/j.medcli.2023.05.030. Epub 2023 Oct 10. No abstract available. English, Spanish. PubMed PMID: 37827889.
AÑO: 2023; IF: 3.9
Martinez Jimenez V, Ortuno Lopez PP, Roca Merono S, Rodriguez Pena L, Galan Carrillo I, Galbis Martinez L, Ramos Carrasco F, Pinero Hernandez JA, Gonzalez Rodriguez JD, Guillen Navarro E; Unidad Multidisciplinar de Enfermedades Renales Hereditarias de la Region de Murcia (UMERH-RM). Oral-facio-digital syndrome type I: In the differential diagnosis of autosomic dominant polycystic kidney disease, about three cases. Nefrologia (Engl Ed). 2023 Mar-Apr;43(2):261-263. doi: 10.1016/j.nefroe.2023.06.002. Epub 2023 Jun 14. No abstract available. PubMed PMID: 37328341.
AÑO: 2023
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII